Iron and Alzheimer's Disease: An Update on Emerging Mechanisms

Journal of Alzheimer's Disease

Volumn 64, Issue s1, 2018, Pages S379-S395

  Lane, Darius J R ^a   Ayton, Scott ^a   Bush, Ashley I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; amyloid ; amyloid protein precursor; apoptosis; astrocytes; ferroptosis; iron; lipid peroxidation; neuroinflammation; oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; IRON; TRANSFERRIN;

ALZHEIMER DISEASE; APOPTOSIS; ASTROCYTE; BRAIN; CELL LOSS; CELL MIGRATION; FERROPTOSIS; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON STORAGE; IRON TRANSPORT; LIPID PEROXIDATION; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEUROFIBRILLARY TANGLE; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ANIMAL; METABOLISM;

ALZHEIMER DISEASE; ANIMALS; HUMANS; IRON;

EID: 85048601057     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-179944     Document Type: Review

References (207)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3, 186-191.
2. Assoc A (2017) Alzheimer's Association Report: 2017 Alzheimer's disease facts and figures. Alzheimers Dement 13, 325-373.
3. Belaidi AA, Bush AI (2016) Iron neurochemistry in Alzheimer's disease and Parkinson'S disease: Targets for therapeutics. J Neurochem 139(Suppl 1), 179-197.
4. Ayton S, Lei P, Bush AI (2013) Metallostasis in Alzheimer's disease. Free Radic Biol Med 62, 76-89.
5. Davydov V, Hansen LA, Shackelford DA (2003) Is DNA repair compromised in Alzheimer's disease Neurobiol Aging 24, 953-968.
6. Good PF, Werner P, Hsu A, Olanow CW, Perl DP (1996) Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 149, 21-28.
7. Mecocci P, MacGarvey U, BealMF(1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36, 747-751.
8. Pratico D (2008) Oxidative stress hypothesis in Alzheimer's disease: A reappraisal. Trends Pharmacol Sci 29, 609-615.
9. Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals. J Neurochem 74, 270-279.
10. Urrutia P, Aguirre P, Esparza A, Tapia V, Mena NP, Arredondo M, Gonzalez-Billault C, Nunez MT (2013) Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem 126, 541-549.
11. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A 88, 10540-10543.
12. Lovell MA, Ehmann WD, Butler SM, Markesbery WR (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
13. Todorich BM, Connor JR (2004) Redox metals in Alzheimer's disease. Ann N Y Acad Sci 1012, 171-178.
14. Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA (2010) Oxidative stress in Alzheimer disease: A possibility for prevention. Neuropharmacology 59, 290-294.
15. Zhu X, Su B,Wang X, Smith MA, Perry G (2007) Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 64, 2202-2210.
16. Yang J, Yang J, Liang SH, Xu Y, Moore A, Ran C (2016) Imaging hydrogen peroxide in Alzheimer's disease via cascade signal amplification. Sci Rep 6, 35613.
17. Di Paolo G, KimTW(2011) Linking lipids to Alzheimer's disease: Cholesterol and beyond. Nat Rev Neurosci 12, 284-296.
18. Gonzalez-Dominguez R, Garcia-Barrera T, Gomez-Ariza JL (2014) Homeostasis of metals in the progression of Alzheimer's disease. Biometals 27, 539-549.
19. Yu J, Guo Y, Sun M, Li B, Zhang Y, Li C (2009) Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons. Brain Res 1257, 102-107.
20. Yang WS, Stockwell BR (2016) Ferroptosis: Death by lipid peroxidation. Trends Cell Biol 26, 165-176.
21. Lawen A, Lane DJR (2013) Mammalian iron homeostasis in health and disease: Uptake, storage, transport, and molecular mechanisms of action. Antioxid Redox Signal 18, 2473-2507.
22. SteinbickerAU,MuckenthalerMU(2013) Out of balance-systemic iron homeostasis in iron-related disorders. Nutrients 5, 3034-3061.
23. Bradley-Whitman MA, Lovell MA (2015) Biomarkers of lipid peroxidation in Alzheimer disease (AD): An update Arch Toxicol 89, 1035-1044.
24. Winterbourn CC (1995) Toxicity of iron and hydrogen peroxide: The Fenton reaction. Toxicol Lett 82-83, 969-974.
25. Ayton S, Lei P, Bush AI (2015) Biometals and their therapeutic implications in Alzheimer's disease. Neurotherapeutics 12, 109-120.
26. Bandyopadhyay S, Rogers JT (2014) Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: Maintenance of brain iron homeostasis. Biochem Pharmacol 88, 486-494.
27. Horowitz MP, Greenamyre JT (2010) Mitochondrial iron metabolism and its role in neurodegeneration. J Alzheimers Dis 20(Suppl 2), S551-568.
28. Buettner GR, Jurkiewicz BA (1996) Catalytic metals, ascorbate and free radicals: Combinations to avoid. Radiat Res 145, 532-541.
29. Lane DJR, Lawen A (2009) Ascorbate and plasma membrane electron transport-enzymes vs efflux. Free Radic Biol Med 47, 485-495.
30. Sagrista ML, Garcia AE, Africa De Madariaga M, Mora M(2002) Antioxidant and pro-oxidant effect of the thiolic compounds N-acetyl-L-cysteine and glutathione against free radical-induced lipid peroxidation. Free Radic Res 36, 329-340.
31. Muckenthaler MU, Galy B, Hentze MW (2008) Systemic iron homeostasis and the iron-responsive element/ironregulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr 28, 197-213.
32. Richardson DR, Lane DJR, Becker EM, Huang ML, Whitnall M, Rahmanto YS, Sheftel AD, Ponka P (2010) Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci U S A 107, 10775-10782.
33. Lane DJ, Merlot AM, Huang ML, Bae DH, Jansson PJ, Sahni S, Kalinowski DS, Richardson DR (2015) Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease. Biochim Biophys Acta 1853, 1130-1144.
34. Arosio P, Levi S (2010) Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim Biophys Acta 1800, 783-792.
35. Lill R (2009) Function and biogenesis of iron-sulphur proteins. Nature 460, 831-838.
36. Rouault TA (2012) Biogenesis of iron-sulfur clusters in mammalian cells: New insights and relevance to human disease. Dis Model Mech 5, 155-164.
37. Philpott CC, RyuMS(2014) Special delivery: Distributing iron in the cytosol of mammalian cells. Front Pharmacol 5, 173.
38. Philpott CC (2012) Coming into view: Eukaryotic iron chaperones and intracellular iron delivery. J Biol Chem 287, 13518-13523.
39. Hentze MW, Kuhn LC (1996) Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A 93, 8175-8182.
40. Richardson DR, Ponka P (1997) The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1331, 1-40.
41. Hentze MW, Muckenthaler MU, Galy B, Camaschella C (2010) Two to tango: Regulation of mammalian iron metabolism. Cell 142, 24-38.
42. Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, Sharp JJ, Fujiwara Y, Barker JE, Fleming MD (2005) Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet 37, 1264-1269.
43. Lane DJ, Richardson DR (2014) The active role of Vitamin C in mammalian iron metabolism: Much more than just enhanced iron absorption! Free Radic Biol Med 75C, 69-83.
44. Lane DJR, Chikhani S, Richardson V, Richardson DR (2013) Transferrin iron uptake is stimulated by ascorbate via an intracellular reductive mechanism. Biochim Biophys Acta 1833, 1527-1541.
45. Escobar A, Gaete V, Nunez MT (1992) Effect of ascorbate in the reduction of transferrin-associated iron in endocytic vesicles. J Bioenerg Biomembr 24, 227-233.
46. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488.
47. Jenkitkasemwong S, Wang CY, Mackenzie B, Knutson MD (2012) Physiologic implications of metal-ion transport by ZIP14 and ZIP8. Biometals 25, 643-655.
48. Yanatori I, Yasui Y, Tabuchi M, Kishi F (2014) Chaperone protein involved in transmembrane transport of iron. Biochem J 462, 25-37.
49. Leidgens S, Bullough KZ, Shi H, Li F, Shakoury-Elizeh M, Yabe T, Subramanian P, Hsu E, Natarajan N, Nandal A, Stemmler TL, Philpott CC (2013) Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin. J Biol Chem 288, 17791-17802.
50. McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, Richardson C, Barlow D, Bomford A, Peters TJ, Raja KB, Shirali S, Hediger MA, Farzaneh F, Simpson RJ (2001) An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291, 1755-1759.
51. Lane DJR, Lawen A (2008) Non-transferrin iron reduction and uptake are regulated by transmembrane ascorbate cycling in K562 cells. J Biol Chem 283, 12701-12708.
52. Lane DJR, Lawen A (2013) The glutamate aspartate transporter (GLAST) mediates L-glutamate-stimulated ascorbate-release via swelling-activated anion channels in cultured neonatal rodent astrocytes. Cell Biochem Biophys 65, 107-119.
53. Lane DJ, Robinson SR, Czerwinska H, BishopGM,Lawen A (2010) Two routes of iron accumulation in astrocytes: Ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron. Biochem J 432, 123-132.
54. Harrison PM, Arosio P (1996) The ferritins: Molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275, 161-203.
55. Chasteen ND, Harrison PM (1999) Mineralization in ferritin: An efficient means of iron storage. J Struct Biol 126, 182-194.
56. De Domenico I, Ward DM, Kaplan J (2009) Specific iron chelators determine the route of ferritin degradation. Blood 114, 4546-4551.
57. Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC (2014) Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509, 105-109.
58. Rouault TA (2006) The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2, 406-414.
59. Guo B, Phillips JD,YuY, LeiboldEA(1995) Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J Biol Chem 270, 21645-21651.
60. Moos T, Nielsen TR, Skjørringe T, Morgan EH(2007) Iron trafficking inside the brain. J Neurochem 103, 1730-1740.
61. Dringen R, Bishop GM, Koeppe M, Dang TN, Robinson SR (2007) The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem Res 32, 1884-1890.
62. Bishop GM, Dang TN, Dringen R, Robinson SR (2011) Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia. Neurotox Res 19, 443-451.
63. Skjorringe T, Burkhart A, Johnsen KB, Moos T (2015) Divalent metal transporter 1 (DMT1) in the brain: Implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology. Front Mol Neurosci 8, 19.
64. Moos T, Skjoerringe T, Gosk S, Morgan EH (2006) Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1. J Neurochem 98, 1946-1958.
65. Benarroch EE (2009) Brain iron homeostasis and neurodegenerative disease. Neurology 72, 1436-1440.
66. Burkhart A, Skjorringe T, Johnsen KB, Siupka P, Thomsen LB, Nielsen MS, Thomsen LL, Moos T (2016) Expression of iron-related proteins at the neurovascular unit supports reduction and reoxidation of iron for transport through the blood-brain barrier. Mol Neurobiol 53, 7237-7253.
67. McCarthy RC, Kosman DJ (2013) Ferroportin and exocytoplasmic ferroxidase activity are required for brain microvascular endothelial cell iron efflux. J Biol Chem 288, 17932-17940.
68. Codazzi F, Pelizzoni I, Zacchetti D, Grohovaz F (2015) Iron entry in neurons and astrocytes: A link with synaptic activity. Front Mol Neurosci 8, 18.
69. Jeong SY, David S (2003) Glycosylphosphatidylinositolanchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 278, 27144-27148.
70. Erikson KM, Aschner M (2006) Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter. Neurotoxicology 27, 125-130.
71. Song N, Jiang H, Wang J, Xie J-X (2007) Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx. J Neurosci Res 85, 3118-3126.
72. Tulpule K, Robinson SR, Bishop GM, Dringen R (2010) Uptake of ferrous iron by cultured rat astrocytes. J Neurosci Res 88, 563-571.
73. Lis A, Barone TA, Paradkar PN, Plunkett RJ, Roth JA (2004) Expression and localization of different forms of DMT1 in normal and tumor astroglial cells. Mol Brain Res 122, 62-70.
74. Burdo JR, Menzies SL, Simpson IA, Garrick LM, Garrick MD, Dolan KG, Haile DJ, Beard JL, Connor JR (2001) Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res 66, 1198-1207.
75. Wang XS, OngWY, Connor JR (2001)Alight and electron microscopic study of the iron transporter protein DMT-1 in the monkey cerebral neocortex and hippocampus. J Neurocytol 30, 353-360.
76. Pelizzoni I, Zacchetti D, Campanella A, Grohovaz F, Codazzi F (2013) Iron uptake in quiescent and inflammation-activated astrocytes: A potentially neuroprotective control of iron burden. Biochim Biophys Acta 1832, 1326-1333.
77. Hubert N, HentzeMW(2002) Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: Implications for regulation and cellular function. Proc Natl Acad Sci U S A 99, 12345-12350.
78. Rathore KI, Redensek A, David S (2012) Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-a and TGF-b1. Glia 60, 738-750.
79. Pelizzoni I, Zacchetti D, Smith CP, Grohovaz F, Codazzi F (2012) Expression of divalent metal transporter 1 in primary hippocampal neurons: Reconsidering its role in non-transferrin-bound iron influx. J Neurochem 120, 269-278.
80. Saura J (2007) Microglial cells in astroglial cultures: A cautionary note. J Neuroinflammation 4, 26.
81. Ayton S, Lei P (2014) Nigral iron elevation is an invariable feature of Parkinson'S disease and is a sufficient cause of neurodegeneration. Biomed Res Int 2014, 581256.
82. Ayton S, Lei P, Adlard PA, Volitakis I, Cherny RA, Bush AI, Finkelstein DI (2014) Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: Implications for Parkinson'S disease. Mol Neurodegener 9, 27.
83. Goodman L (1953) Alzheimer's disease; a clinicopathologic analysis of twenty-three cases with a theory on pathogenesis. J Nerv Ment Dis 118, 97-130.
84. Connor JR, Menzies SL, St Martin SM, Mufson EJ (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 31, 75-83.
85. Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ (1992) Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res 31, 327-335.
86. Collingwood JF, Mikhaylova A, Davidson M, Batich C, Streit WJ, Terry J, Dobson J (2005) In situ characterization and mapping of iron compounds in Alzheimer's disease tissue. J Alzheimers Dis 7, 267-272.
87. Baltes C, Princz-Kranz F, Rudin M, Mueggler T (2011) Detecting amyloid-beta plaques in Alzheimer's disease. Methods Mol Biol 711, 511-533.
88. Meadowcroft MD, Connor JR, Smith MB, Yang QX (2009) MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J Magn Reson Imaging 29, 997-1007.
89. Collingwood JF, Chong RK, Kasama T, Cervera-Gontard L, Dunin-Borkowski RE, Perry G, Posfai M, Siedlak SL, Simpson ET, Smith MA, Dobson J (2008) Threedimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J Alzheimers Dis 14, 235-245.
90. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez KA, Johanssen TJ, Greenough MA, Cho H-H, Galatis D, Moir RD, Masters CL, Mclean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, Bush AI (2010) Iron-export ferroxidase activity of-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867.
91. Andrasi E, Farkas E, Scheibler H, Reffy A, Bezur L (1995) Al, Zn, Cu, Mn and Fe levels in brain in Alzheimer's disease. Arch Gerontol Geriatr 21, 89-97.
92. Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redoxgenerated free radicals. Proc Natl Acad Sci U S A 94, 9866-9868.
93. Pietrzak RH, Lim YY, Ames D, Harrington K, Restrepo C, Martins RN, Rembach A, Laws SM, Masters CL, Villemagne VL, Rowe CC, Maruff P, Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group (2015) Trajectories of memory decline in preclinical Alzheimer's disease: Results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageing. Neurobiol Aging 36, 1231-1238.
94. Ayton S, Fazlollahi A, Bourgeat P, Raniga P, Ng A, Lim YY, Diouf I, Farquharson S, Fripp J, Ames D, Doecke J, Desmond P, Ordidge R, Masters CL, Rowe CC, Maruff P, Villemagne VL, Australian Imaging B, Lifestyle Research G, Salvado O, Bush AI (2017) Cerebral quantitative susceptibility mapping predicts amyloid-related cognitive decline. Brain 140, 2112-2119.
95. Ayton S, Faux NG, Bush AI (2017) Association of cerebrospinal fluid ferritin level with preclinical cognitive decline in APOE-4 carriers. JAMA Neurol 74, 122-125.
96. Ayton S, Faux NG, Bush AI, Alzheimer's Disease Neuroimaging Initiative (2015) Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nat Commun 6, 6760.
97. Braughler JM, Duncan LA, Chase RL (1986) The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation. J Biol Chem 261, 10282-10289.
98. Dougherty JJ, Croft WA, Hoekstra WG (1981) Effects of ferrous chloride and iron dextran on lipid peroxidation in vivo in Vitamin E and selenium adequate and deficient rats. J Nutr 111, 1784-1796.
99. Morris G, Berk M, Carvalho AF, Maes M,Walker AJ, Puri BK (2018) Why should neuroscientists worry about iron The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases. Behav Brain Res 341, 154-175.
100. Hare D, Ayton S, Bush A, Lei P (2013) A delicate balance: Iron metabolism and diseases of the brain. Front Aging Neurosci 5, 34.
101. Li X, Liu Y, Zheng Q, Yao G, Cheng P, Bu G, Xu H, ZhangYW(2013) Ferritin light chain interacts with PEN-2 and affects gamma-secretase activity. Neurosci Lett 548, 90-94.
102. Peters DG, Pollack AN, Cheng KC, Sun D, Saido T, Haaf MP, Yang QX, Connor JR, Meadowcroft MD (2018) Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice. Metallomics 10, 426-443.
103. Gurel B, Cansev M, Sevinc C, Kelestemur S, Ocalan B, Cakir A, Aydin S, Kahveci N, Ozansoy M, Taskapilioglu O, Ulus IH, Basar MK, Sahin B, Tuzuner MB, Baykal AT (2018) Early stage alterations in CA1 extracellular region proteins indicate dysregulation of IL6 and iron homeostasis in the 5XFAD Alzheimer's disease mouse model. J Alzheimers Dis 61, 1399-1410.
104. Ayton SJ, Diouf I, Bush AI (2018) Evidence that iron accelerates Alzheimer's pathology: A CSF biomarker study. J Neurol Neurosurg Psychiatry 89, 456-460.
105. Telling ND, Everett J, Collingwood JF, Dobson J, van der Laan G, Gallagher JJ, Wang J, Hitchcock AP (2017) Iron biochemistry is correlated with amyloid plaque morphology in an established mouse model of Alzheimer's disease. Cell Chem Biol 24, 1205-1215.e1203.
106. Greenough MA (2016) The role of presenilin in protein trafficking and degradation-implications for metal homeostasis. J Mol Neurosci 60, 289-297.
107. Garća de Ancos J, Correas I, Avila J (1993) Differences in microtubule binding and self-association abilities of bovine brain tau isoforms. J Biol Chem 268, 7976-7982.
108. LedesmaMD,Avila J, Correas I (1995) Isolation of a phosphorylated soluble tau fraction from Alzheimer's disease brain. Neurobiol Aging 16, 515-522.
109. Yamamoto A, Shin R-W, Hasegawa K, Naiki H, Sato H, Yoshimasu F, Kitamoto T (2002) Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: Implications in the formation of neurofibrillary tangles of Alzheimer's disease. J Neurochem 82, 1137-1147.
110. Guo C, Wang P, Zhong ML, Wang T, Huang XS, Li JY, Wang ZY (2013) Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain. Neurochem Int 62, 165-172.
111. Wang P, Wang ZY (2017) Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease. Ageing Res Rev 35, 265-290.
112. Kuperstein F, Yavin E (2003) Pro-apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity. J Neurochem 86, 114-125.
113. Radi E, Formichi P, Battisti C, Federico A (2014) Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis 42(Suppl 3), S125-152.
114. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter L, McPhee J, Sarang SS, UtsukiT, Greig NH, Lahiri DK, Tanzi RE, Bush AI, Giordano T, Gullans SR (2002) An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem 277, 45518-45528.
115. Cho HH, Cahill CM, Vanderburg CR, Scherzer CR,Wang B, Huang X, Rogers JT (2010) Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J Biol Chem 285, 31217-31232.
116. Paul VD, LillR(2015) Biogenesis of cytosolic and nuclear iron-sulfur proteins and their role in genome stability. Biochim Biophys Acta 1853, 1528-1539.
117. Rouault TA, Maio N (2017) Biogenesis and functions of mammalian iron-sulfur proteins in the regulation of iron homeostasis and pivotal metabolic pathways. J Biol Chem 292, 12744-12753.
118. Isaya G (2014) Mitochondrial iron-sulfur cluster dysfunction in neurodegenerative disease. Front Pharmacol 5, 29.
119. Mena NP, Urrutia PJ, Lourido F, Carrasco CM, Nunez MT (2015) Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders. Mitochondrion 21, 92-105.
120. Rogers JT, Bush AI, Cho HH, Smith DH, Thomson AM, Friedlich AL, Lahiri DK, Leedman PJ, Huang X, Cahill CM (2008) Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: Riboregulation against neural oxidative damage in Alzheimer's disease. Biochem Soc Trans 36, 1282-1287.
121. Smith MA, Wehr K, Harris PL, Siedlak SL, Connor JR, Perry G (1998) Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res 788, 232-236.
122. Yamauchi T, Nishiyama M, Moroishi T, Kawamura A, Nakayama KI (2017) FBXL5 inactivation in mouse brain induces aberrant proliferation of neural stem progenitor cells. Mol Cell Biol 37, e00470-16.
123. Becerril-Ortega J, Bordji K, Freret T, Rush T, Buisson A (2014) Iron overload accelerates neuronal amyloid-b production and cognitive impairment in transgenic mice model of Alzheimer's disease. Neurobiol Aging 35, 2288-2301.
124. Zhang L, Zhao B, Yew DT, Kusiak JW, Roth GS (1997) Processing of Alzheimer's amyloid precursor protein during H2O2-induced apoptosis in human neuronal cells. Biochem Biophys Res Commun 235, 845-848.
125. Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, Tanzi RE, Bush AI (2000) Characterization of copper interactions with Alzheimer amyloid beta peptides: Identification of an attomolar-affinity copper binding site on amyloid beta1-42. J Neurochem 75, 1219-1233.
126. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, Hartshorn MA, Tanzi RE, Bush AI (1998) Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273, 12817-12826.
127. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158, 47-52.
128. James SA, Churches QI, de Jonge MD, Birchall IE, Streltsov V, McColl G, Adlard PA, Hare DJ (2017) Iron, copper, and zinc concentration in A-plaques in the APP/PS1 mouse model of Alzheimer's disease correlates with metal levels in the surrounding neuropil. ACS Chem Neurosci 8, 629-637.
129. Guo C, Wang T, Zheng W, Shan ZY, Teng WP, Wang ZY (2013) Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease. Neurobiol Aging 34, 562-575.
130. Fine JM, Renner DB, Forsberg AC, Cameron RA, Galick BT, Le C, Conway PM, Stroebel BM, FreyWH II, Hanson LR (2015) Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation. Neurosci Lett 584, 362-367.
131. Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337, 1304-1308.
132. Schubert D, Chevion M (1995) The role of iron in beta amyloid toxicity. Biochem Biophys ResCommun216, 702-707.
133. Liu B, Moloney A,Meehan S, Morris K, Thomas SE, Serpell LC, Hider R, Marciniak SJ, Lomas DA, Crowther DC (2011) Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J Biol Chem 286, 4248-4256.
134. Rottkamp CA, Raina AK, Zhu XW, Gaier E, Bush AI, Atwood CS, Chevion M, Perry G, Smith MA (2001) Redox-active iron mediates amyloid-beta toxicity. Free Radic Biol Med 30, 447-450.
135. Rival T, Page RM, Chandraratna DS, Sendall TJ, Ryder E, Liu B, Lewis H, Rosahl T, Hider R, Camargo LM, Shearman MS, Crowther DC, Lomas DA (2009) Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur J Neurosci 29, 1335-1347.
136. Hanson LR, Frey WH II (2008) Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 9(Suppl 3), S5.
137. Lovell MA, Xiong S, Xie C, Davies PL, Markesbery WR (2004) Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. J Alzheimers Dis 6, 659-671; discussion 673-681.
138. Chan A, Shea TB (2006) Dietary and genetically-induced oxidative stress alter tau phosphorylation: Influence of folate and apolipoprotein E deficiency. J Alzheimers Dis 9, 399-405.
139. Huang X, Dai J, Huang C, Zhang Q, Bhanot O, Pelle E (2007) Deferoxamine synergistically enhances ironmediated AP-1 activation: A showcase of the interplay between extracellular-signal-regulated kinase and tyrosine phosphatase. Free Radic Res 41, 1135-1142.
140. Mũnoz P, Zavala G, Castillo K, Aguirre P, Hidalgo C, Nũnez MT (2006) Effect of iron on the activation of the MAPK/ERK pathway in PC12 neuroblastoma cells. Biol Res 39, 189-190.
141. Jin Jung K, Hyun Kim D, Kyeong Lee E, Woo Song C, Pal Yu B, Young Chung H (2013) Oxidative stress induces inactivation of protein phosphatase 2A, promoting proinflammatory NF-kB in aged rat kidney. Free Radic Biol Med 61, 206-217.
142. Gamblin TC, King ME, Kuret J, Berry RW, Binder LI (2000) Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry 39, 14203-14210.
143. Ksiezak-Reding H, Binder LI, Yen S-HC (1988) Immunochemical and biochemical characterization of tau proteins in normal and Alzheimer's disease brains with Alz 50 and Tau-1. J Biol Chem 263, 7948-7953.
144. Khatoon S, Grundke-Iqbal I, Iqbal K (1994) Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett 351, 80-84.
145. ZhukarevaV, Sundarraj S, Mann D, Sjogren M, BlenowK, Clark CM, McKeel DW, Goate A, Lippa CF, Vonsattel JP, Growdon JH, Trojanowski JQ, Lee VM (2003) Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: An international follow-up study. Acta Neuropathol 105, 469-476.
146. van Eersel J, Bi M, Ke YD, Hodges JR, Xuereb JH, Gregory GC, Halliday GM, Gotz J, Kril JJ, Ittner LM (2009) Phosphorylation of soluble tau differs in Pick'S disease and Alzheimer's disease brains. J Neural Transm 116, 1243-1251.
147. Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, Wong BXW, Adlard PA, Cherny RA, Lam LQ, Roberts BR, Volitakis I, Egan GF, Mclean CA, Cappai R, Duce JA, Bush AI (2012) Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med 18, 291-295.
148. McCarthy RC, Park YH, Kosman DJ (2014) sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin. EMBO Rep 15, 809-815.
149. Ayton S, Zhang M, Roberts BR, Lam LQ, Lind M, McLean C, Bush AI, Frugier T, Crack PJ, Duce JA (2014) Ceruloplasmin and beta-amyloid precursor protein confer neuroprotection in traumatic brain injury and lower neuronal iron. Free Radic Biol Med 69, 331-337.
150. Wong BX, Tsatsanis A, Lim LQ, Adlard PA, Bush AI, Duce JA(2014) b-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS One 9, e114174.
151. Salvador GA, Uranga RM, Giusto NM (2010) Iron and mechanisms of neurotoxicity. Int J Alzheimers Dis 2011, 720658.
152. Mark RJ, Hensley K, Butterfield DA, Mattson MP (1995) Amyloid b-peptide impairs ion-motive ATPase activities: Evidence for a role in loss of neuronal Ca2+ homeostasis and cell death. J Neurosci 15, 6239-6249.
153. Ahuja RP, Borchman D, Dean WL, Paterson CA, Zeng J, Zhang Z, Ferguson-Yankey S, Yappert MC (1999) Effect of oxidation on Ca2+-ATPase activity and membrane lipids in lens epithelial microsomes. Free Radic Biol Med 27, 177-185.
154. Moreau VH, Castilho RF, Ferreira ST, Carvalho-Alves PC (1998) Oxidative damage to sarcoplasmic reticulum Ca2+-ATPase at submicromolar iron concentrations: Evidence for metal-catalyzed oxidation. Free Radic Biol Med 25, 554-560.
155. Kaplan P, Matejovicova M, Mezesova V (1997) Ironinduced inhibition of Na+, K+-ATPase and Na+/Ca2+ exchanger in synaptosomes: Protection by the pyridoindole stobadine. Neurochem Res 22, 1523-1529.
156. Gnana-Prakasam JP, Thangaraju M, Liu K, Ha Y, Martin PM, Smith SB, Ganapathy V (2009) Absence of iron-regulatory protein Hfe results in hyperproliferation of retinal pigment epithelium: Role of cystine/glutamate exchanger. Biochem J 424, 243-252.
157. Mitchell RM, Lee SY, Simmons Z, Connor JR (2011) HFE polymorphisms affect cellular glutamate regulation. Neurobiol Aging 32, 1114-1123.
158. Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, Kasarskis E, Mattson MP (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 44, 819-824.
159. Pedersen WA, Chan SL, Mattson MP (2000) A mechanism for the neuroprotective effect of apolipoprotein E: Isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal. J Neurochem 74, 1426-1433.
160. Keller JN, Mark RJ, Bruce AJ, Blanc E, Rothstein JD, Uchida K, Waeg G, Mattson MP (1997) 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80, 685-696.
161. StrugatskyD, Gottschalk KE, Goldshleger R, Bibi E, Karlish SJ (2003) Expression of Na+,K+-ATPase in Pichia pastoris: Analysis of wild type and D369N mutant proteins by Fe2+-catalyzed oxidative cleavage and molecular modeling. J Biol Chem 278, 46064-46073.
162. Munoz P, Humeres A, Elgueta C, Kirkwood A, Hidalgo C, Nunez MT (2011) Iron mediates N-methyl-D-aspartate receptor-dependent stimulation of calcium-induced pathways and hippocampal synaptic plasticity. J Biol Chem 286, 13382-13392.
163. Jiang X, Mu D, Biran V, Faustino J, Chang S, Rincon CM, Sheldon RA, Ferriero DM (2008) Activated Src kinases interact with the N-methyl-D-aspartate receptor after neonatal brain ischemia. Ann Neurol 63, 632-641.
164. Nakamichi N, Ohno H, Nakamura Y, Hirai T, Kuramoto N, Yoneda Y (2002) Blockade by ferrous iron of Ca2+ influx through N-methyl-D-aspartate receptor channels in immature cultured rat cortical neurons. J Neurochem 83, 1-11.
165. Shinkyo R, Guengerich FP (2011) Cytochrome P450 7A1 cholesterol 7alpha-hydroxylation: Individual reaction steps in the catalytic cycle and rate-limiting ferric iron reduction. J Biol Chem 286, 4632-4643.
166. Graham RM, Chua AC, Carter KW, Delima RD, Johnstone D, Herbison CE, Firth MJ, O'Leary R, Milward EA, Olynyk JK, Trinder D (2010) Hepatic iron loading in mice increases cholesterol biosynthesis. Hepatology 52, 462-471.
167. Kraml PJ, Klein RL, Huang Y, Nareika A, Lopes-Virella MF (2005) Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes. Metabolism 54, 453-459.
168. Francis N, Wong SH, Hampson P, Wang K, Young SP, Deigner HP, Salmon M, Scheel-Toellner D, Lord JM (2011) Lactoferrin inhibits neutrophil apoptosis via blockade of proximal apoptotic signaling events. Biochim Biophys Acta 1813, 1822-1826.
169. Yurkova I, Kisel M, Arnhold J, Shadyro O (2005) Ironmediated free-radical formation of signaling lipids in a model system. Chem Phys Lipids 137, 29-37.
170. Yehuda S, Rabinovitz-Shenkar S, Carasso RL (2011) Effects of essential fatty acids in iron deficient and sleepdisturbed attention deficit hyperactivity disorder (ADHD) children. Eur J Clin Nutr 65, 1167-1169.
171. LeBlanc CP, Fiset S, Surette ME, Turgeon O'Brien H, Rioux FM (2009) Maternal iron deficiency alters essential fatty acid and eicosanoid metabolism and increases locomotion in adult guinea pig offspring. J Nutr 139, 1653-1659.
172. Brown KE, Dennery PA, Ridnour LA, Fimmel CJ, Kladney RD, Brunt EM, Spitz DR (2003) Effect of iron overload and dietary fat on indices of oxidative stress and hepatic fibrogenesis in rats. Liver Int 23, 232-242.
173. Isaac G, Fredriksson A, Danielsson R, Eriksson P, Bergquist J (2006) Brain lipid composition in postnatal iron-induced motor behavior alterations following chronic neuroleptic administration in mice. FEBS J 273, 2232-2243.
174. Jenkins KJ, Kramer JK (1988) Effect of excess dietary iron on lipid composition of calf liver, heart, and skeletal muscle. J Dairy Sci 71, 435-441.
175. Mattson MP (2004) Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders. Ann N Y Acad Sci 1012, 37-50.
176. Lassmann H, Bancher C, Breitschopf H,Wegiel J, Bobinski M, Jellinger K, Wisniewski HM (1995) Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89, 35-41.
177. Woodhouse A, Dickson TC, West AK, McLean CA, Vickers JC (2006) No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases. Neurobiol Dis 22, 323-333.
178. Higuchi Y (2003) Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress. Biochem Pharmacol 66, 1527-1535.
179. Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascon S, Hatzios SK, Kagan VE, Noel K, Jiang X, Linkermann A, Murphy ME, Overholtzer M, Oyagi A, Pagnussat GC, Park J, Ran Q, Rosenfeld CS, Salnikow K, Tang D, Torti FM, Torti SV, Toyokuni S, Woerpel KA, Zhang DD (2017) Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171, 273-285.
180. Hambright WS, Fonseca RS, Chen L, Na R, Ran Q (2017) Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol 12, 8-17.
181. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B, Stockwell BR (2012) Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 149, 1060-1072.
182. Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, AramaE, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, DiVirgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, Garcia-Saez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jaattela M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, LeeSW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, Lopez-Otin C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Munoz-Pinedo C, Nagata S, Nunez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, ShiY, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D,Wagner EF,Walczak H,Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G (2018) Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 25, 486-541.
183. Cao JY, Dixon SJ (2016) Mechanisms of ferroptosis. Cell Mol Life Sci 73, 2195-2209.
184. Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R, Tang D (2016) Ferroptosis: Process and function. Cell Death Differ 23, 369-379.
185. Kang R,TangD(2017) Autophagy and ferroptosis-what'S the connection Curr Pathobiol Rep 5, 153-159.
186. Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X (2016) Ferroptosis is an autophagic cell death process. Cell Res 26, 1021-1032.
187. Neitemeier S, Jelinek A, Laino V, Hoffmann L, Eisenbach I, Eying R, Ganjam GK, Dolga AM, Oppermann S, Culmsee C (2017) BID links ferroptosis to mitochondrial cell death pathways. Redox Biol 12, 558-570.
188. Jelinek A, Heyder L, Daude M, Plessner M, Krippner S, Grosse R, Diederich WE, Culmsee C (2018) Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis. Free Radic Biol Med 117, 45-57.
189. Shah R, Margison K, Pratt DA (2017) The potency of diarylamine radical-trapping antioxidants as inhibitors of ferroptosis underscores the role of autoxidation in the mechanism of cell death. ACS Chem Biol 12, 2538-2545.
190. Zilka O, Shah R, Li B, Friedmann Angeli JP, Griesser M, Conrad M, Pratt DA (2017) On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci 3, 232-243.
191. Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, StockwellBR(2016) Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A 113, E4966-4975.
192. Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, Dar HH, Liu B, TyurinVA, Ritov VB, Kapralov AA, Amoscato AA, Jiang J, Anthonymuthu T, Mohammadyani D, Yang Q, Proneth B, Klein-Seetharaman J, Watkins S, Bahar I, Greenberger J, Mallampalli RK, Stockwell BR, Tyurina YY, Conrad M, Bayir H (2017) Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol 13, 81-90.
193. Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A, Prokisch H, Trumbach D, Mao G, Qu F, Bayir H, Fullekrug J, Scheel CH, Wurst W, Schick JA, Kagan VE, Angeli JP, Conrad M (2017) ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 13, 91-98.
194. Epperly T, Dunay MA, Boice JL (2017) Alzheimer disease: Pharmacologic and nonpharmacologic therapies for cognitive and functional symptoms. Am Fam Physician 95, 771-778.
195. Gugliandolo A, Bramanti P, Mazzon E (2017) Role of Vitamin E in the treatment of Alzheimer's disease: Evidence from animal models. Int J Mol Sci 18, E2504.
196. Kryscio RJ, Abner EL, Caban-Holt A, Lovell M, Goodman P, Darke AK, Yee M, Crowley J, Schmitt FA (2017) Association of antioxidant supplement use and dementia in the Prevention of Alzheimer's Disease byVitamin E and SeleniumTrial (PREADViSE). JAMANeurol 74, 567-573.
197. Cervantes B, Ulatowski LM (2017) Vitamin E and Alzheimer's disease-is it time for personalized medicine Antioxidants (Basel) 6, E45.
198. Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R, Gu W (2015) Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520, 57-62.
199. Ou Y, Wang SJ, Li D, Chu B, Gu W (2016) Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci U S A 113, E6806-e6812.
200. Lane DJR, Bae D-H, Siafakas AR, Rahmanto YS, Al-Akra L, Jansson PJ, Casero RA Jr, Richardson DR (2018) Coupling of the polyamine and iron metabolism pathways in the regulation of proliferation: Mechanistic links to alterations in key polyamine biosynthetic and catabolic enzymes. BBA-Mol Basis Dis [Epub ahead of print] doi: 10.1016/j.bbadis.2018.05.007
201. Fricker M, Tolkovsky AM, Borutaite V, Coleman M, Brown GC (2018) Neuronal cell death. Physiol Rev 98, 813-880.
202. Guiney SJ, Adlard PA, Bush AI, Finkelstein DI, Ayton S (2017) Ferroptosis and cell death mechanisms in Parkinson'S disease. Neurochem Int 104, 34-48.
203. Tuo QZ, Lei P, Jackman KA, Li XL, Xiong H, Li XL, Liuyang ZY, Roisman L, Zhang ST, Ayton S, Wang Q, Crouch PJ, Ganio K, Wang XC, Pei L, Adlard PA, Lu YM, Cappai R, Wang JZ, Liu R, Bush AI (2017) Taumediated iron export prevents ferroptotic damage after ischemic stroke. Mol Psychiatry 22, 1520-1530.
204. Chen L, Hambright WS, Na R, Ran Q (2015) Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. J Biol Chem 290, 28097-28106.
205. Kirouac L, Rajic AJ, Cribbs DH, Padmanabhan J (2017) Activation of Ras-ERK signaling and GSK-3 by amyloid precursor protein and amyloid beta facilitates neurodegeneration in Alzheimer's disease. eNeuro 4, ENEURO.0149-16.2017.
206. Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM, Boniface JJ, Smith R, Lessnick SL, Sahasrabudhe S, Stockwell BR (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447, 864-868.
207. Yang WS, Stockwell BR (2008) Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol 15, 234-245